Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Springer full text link Springer
Full text links

Actions

Share

Review
.2020 Feb 8;22(2):6.
doi: 10.1007/s11940-020-0613-y.

Epilepsy in brain metastasis: an emerging entity

Affiliations
Review

Epilepsy in brain metastasis: an emerging entity

Roberta Rudà et al. Curr Treat Options Neurol..

Abstract

Purpose of review: The purpose of this review is to highlight advances in the management of seizures in brain metastases from solid tumors.

Recent findings: The highest risk for seizures is in patients with melanoma and lung cancer. There is lack of data on the efficacy of antiepileptic drugs (AEDs), but interactions between enzyme-inducing AEDs and anticancer agents must be avoided. Levetiracetam and valproic acid are the most appropriate drugs. Prophylaxis with AEDs for patients with brain metastases without a history of seizures is not recommended. Total resection of a brain metastasis allows complete seizure control. Seizures may represent an adverse effect of stereotactic radiosurgery or of high-dose chemotherapy. New preclinical and clinical studies should define the risk of brain metastasis in light of the new treatment options in the different tumor types. New clinical trials should be designed in patients with brain metastases in terms of treatment or prophylaxis of seizures.

Keywords: Antiepileptic drugs; Brain metastases; Epilepsy; Interactions; Seizures.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Neuro Oncol. 2017 Feb 1;19(2):162-174 - PubMed
    1. J Neurooncol. 2005 May;72(3):255-60 - PubMed
    1. Clin Transl Oncol. 2018 Dec;20(12):1571-1576 - PubMed
    1. Clin Colorectal Cancer. 2009 Mar;8(2):100-5 - PubMed
    1. J Neurooncol. 2008 Jan;86(1):61-70 - PubMed

Publication types

Related information

LinkOut - more resources

Full text links
Springer full text link Springer
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp